Clinical Trial Banner

Clinical Trial Information

Ali Naji

Principal Investigator: Ali Naji, MD

Title: CIT 07 Islet Cell Transplantation in Type 1 Diabetes

Sponsor: National Institutes of Health

Objective: To establish the efficacy of a novel immunosuppression approach in islet transplantation as a treatment for type 1 diabetes complicated by severe hypoglycemia.

Eligibility: The study is presently recruiting type 1 diabetic patients with severe problems with hypoglycemia.

Contact Info:

Eileen Markmann, BSN, RN
Phone: 215-662-4449
E-mail: eileen.markmann@uphs.upenn.edu

Maral Palanjian, BSN, RN
Phone: 215-615-3727